Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure

Obesity Surgery

Volumn 26, Issue 5, 2016, Pages 1081-1089

  Espinos J C ^a   Turro R ^a   Moragas, G ^b   Bronstone, A ^c   Buchwald, J N ^c   Mearin, F ^a   Mata, A ^a   Uchima, H ^a   Turro J ^a   Delgado Aros, S ^d  

^a Radiology Service   (Spain)

^b CETIR Grup Medic   (Spain)

^c Division of Scientific Writing   (United States)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

Bariatric surgery; Glucose homeostasis; Hormones; Incisionless Operating Platform; POSE; Satiety; Weight loss

Indexed keywords

C PEPTIDE; GHRELIN; GLUCOSE; INSULIN; LEPTIN; PEPTIDE YY [3-36]; GLUCOSE BLOOD LEVEL; PEPTIDE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; NUTRITIONAL ASSESSMENT; OBESITY; OPERATION DURATION; PRIMARY OBESITY SURGERY ENDOLUMENAL; PRIORITY JOURNAL; SATIETY; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH FUNDUS; STOMACH SCINTISCANNING; WEIGHT CHANGE; WEIGHT REDUCTION; ANALYSIS; FOOD INTAKE; GASTROSCOPY; HOMEOSTASIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; PROCEDURES; STOMACH; YOUNG ADULT;

ADULT; APPETITE REGULATION; BARIATRIC SURGERY; BLOOD GLUCOSE; ENERGY INTAKE; FEMALE; GASTRIC EMPTYING; GASTRIC FUNDUS; GASTROSCOPY; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; OBESITY; PEPTIDES; POSTPRANDIAL PERIOD; STOMACH; WEIGHT LOSS; YOUNG ADULT;

EID: 84940703339     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1863-8     Document Type: Article

References (38)

1. Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:Cd003641.
2. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;m24(3):437–55.
3. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
4. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.
5. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.
6. Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.
7. Espinos JC, Turro R, Mata A, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg. 2013;23(9):1375–83.
8. Lopez-Nava G, Bautistia-Castaño I, Jiminez A, et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2014, in press.
9. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol. 2004;286(1):G7–13.
10. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15(6):367–78.
11. Delgado-Aros S, Cremonini F, Castillo JE, et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004;126:432–40.
12. Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterol. 2006;131:1717–24.
13. Moragas G, Azpirov F, Pavia J, et al. Relations among intragastric pressure, postcibal perception, and gastric emptying. Am J Physiol. 1993;246(6 Part 1):G1112–7.
14. Gras-Miralles B, Haya JR, Moros JM, et al. Caloric intake capacity as measured by a standard nutrient drink test helps to predict weight loss after bariatric surgery. Obes Surg. 2014;24(12):2138–44.
15. Puigvehi M, Gras-Miralles B, Torra S, et al. Comparison of ad-libitum energy intake and the neuro-endocrine postprandial response as measured during a buffet-type meal and a standardized nutrient drink test. Gastroenterology 2012; 142:S-56.
16. Torra S, Ilzarbe L, Malagelada JR, et al. Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial). Int J Obes (Lond). 2011;35(6):829–37.
17. Meyer-Gerspach AC, Wölnerhanssen B, Beglinger B, et al. Gastric and intestinal satiation in obese and normal weight healthy people. Physiol Behav. 2014;129:265–71.
18. Camilleri M, Colemont LJ, Phillips SF, et al. Human gastric emptying and colonic filling of solids characterized by a method. Am J Physiol. 1989;257(2 Part 1):G284–90.
19. Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74(5):943–53.
20. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
21. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.
22. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104–9.
23. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141(11):4255–61.
24. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–9.
25. Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–9.
26. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623–30.
27. Morinigo R, Vidal J, Lacy AM, et al. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg. 2008;247(2):270–5.
28. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, et al. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985;89:1070–7.
29. Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol. 2014;592:2927–41.
30. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–7.
31. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941–8.
32. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780–5.
33. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14(9):1553–61.
34. Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflamm. 2010;7:37.
35. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–9.
36. Cervero F, Laird JM. Visceral pain. Lancet. 1999;353:2145–8.
37. Tack J, Demedts I, Dehondt G, et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterol. 2002;122:1738–47.
38. Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterol. 2005;129:98–104.